Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jun 28;8(2):200-214.
doi: 10.14218/JCTH.2020.00009. Epub 2020 Apr 24.

Herb-induced Liver Injury in Asia and Current Role of RUCAM for Causality Assessment in 11,160 Published Cases

Affiliations
Review

Herb-induced Liver Injury in Asia and Current Role of RUCAM for Causality Assessment in 11,160 Published Cases

Rolf Teschke et al. J Clin Transl Hepatol. .

Abstract

Herb-induced liver injuries (HILI) by traditional herbal medicines are particular challenges in Asian countries, with issues over the best approach to establish causality. The aim of the current analysis was to provide an overview on how causality was assessed in HILI cases from Asian countries and whether the Roussel Uclaf Causality Assessment Method (RUCAM) was the preferred diagnostic algorithm, as shown before in worldwide evaluated cases of drug-induced liver injury (DILI). Using the PubMed database, publications in English language were preferred to allow for reevaluation by peers. Overall 11,160 HILI cases have assessed causality using RUCAM and were published by first authors working in Asian countries. With 21 evaluable reports, most publications came from mainland China, with Hong Kong and Taiwan, followed by Korea (n=15), Singapore (n=2), and Japan (n=1), while other Asian countries were not contributory. Most publications provided case and RUCAM data of good quality. For better presentation of future cases, however, the following recommendations are given: (1) preference of prospective study design with use of the updated RUCAM version; (2) clear separation of HILI cohorts from those of other herbal products or DILI; (3) case series for epidemiology studies should contain many essential data, possibly also as supplementary material; (4) otherwise, preference of single case reports providing individual case data and RUCAM-based causality gradings, and applying liver test threshold values; and (5) publication in English language journals. In conclusion, China and Korea are top in presenting RUCAM-based HILI cases, other Asian countries are encouraged to follow.

Keywords: Drug induced liver injury; Herb induced liver injury; Liver injury; RUCAM.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflict of interests related to this publication.

Figures

Fig. 1.
Fig. 1.. Flowchart depicting the diagnosis strategy of herb induced liver injury, adapted from the Chinese guidelines for the diagnosis and management of herb-induced liver injury. Thresholds of ALT and ALP are in line with the updated RUCAM. Establishing the RUCAM-based diagnosis of HILI requires RUCAM scores of ≥6 that provide causality gradings of probable or highly probable. Additional search for herbal authentications, adulterations, toxin contaminations, and biomarkers may be needed.Abbreviations: ALP, alkaline phosphatase; ALT, alanine aminotransferase; RUCAM, Roussel Uclaf Causality Assessment Method; ULN, upper limit of normal.

Similar articles

Cited by

References

    1. Teschke R, Schwarzenboeck A, Schmidt-Taenzer W, Wolff A, Hennermann KH. Herb induced liver injury presumably caused by black cohosh: a survey of initially purported cases and herbal quality specifications. Ann Hepatol. 2011;10:249–259. doi: 10.1016/S1665-2681(19)31536-4. - DOI - PubMed
    1. Teschke R, Glass X, Schulze J. Herbal hepatotoxicity by Greater Celandine (Chelidonium majus): causality assessment of 22 spontaneous reports. Regul Toxicol Pharmacol. 2011;61:282–291. doi: 10.1016/j.yrtph.2011.08.008. - DOI - PubMed
    1. Brown AC. Liver toxicity related to herbs and dietary supplements: Online table of case reports. Part 2 of 5 series. Food Chem Toxicol. 2017;107:472–501. doi: 10.1016/j.fct.2016.07.001. - DOI - PubMed
    1. Meunier L, Larrey D. Drug-induced liver injury: Biomarkers, requirements, candidates, and validation. Front Pharmacol. 2019;10:1482. doi: 10.3389/fphar.2019.01482. - DOI - PMC - PubMed
    1. Teschke R, Eickhoff A, Schulze J. Drug- and herb-induced liver injury in clinical and translational hepatology: Causality assessment methods, Quo Vadis? J Clin Transl Hepatol. 2013;1:59–74. doi: 10.14218/JCTH.2013.D002X. - DOI - PMC - PubMed